Celularity Inc. (CELU)
NASDAQ: CELU
· Real-Time Price · USD
1.57
0.08 (5.37%)
At close: May 01, 2025, 3:59 PM
1.55
-1.27%
After-hours: May 01, 2025, 04:26 PM EDT
5.37% (1D)
| Bid | 1.52 |
| Market Cap | 37.38M |
| Revenue (ttm) | 48.2M |
| Net Income (ttm) | -35.05M |
| EPS (ttm) | -100.39 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -0.33 |
| Analyst | n/a |
| Ask | 1.61 |
| Volume | 15,937 |
| Avg. Volume (20D) | 149,857 |
| Open | 1.54 |
| Previous Close | 1.49 |
| Day's Range | 1.54 - 1.58 |
| 52-Week Range | 1.00 - 5.22 |
| Beta | 0.58 |
About CELU
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 8, 2019
Employees 120
Stock Exchange NASDAQ
Ticker Symbol CELU
Website https://www.celularity.com
5 months ago
+12.6%
Celularity shares are trading higher. The Nasdaq L...
Unlock content with
Pro Subscription
5 months ago
+113.1%
Celularity shares are trading higher after the company announced it raised its FY24 sales guidance from $50-$60M to $54-$60M.
